FRA
GMED icon

Front Row Advisors’s Globus Medical GMED Stock Holding History

Front Row Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-125
Closed -$8.56K – 643
2024
Q2 		$8.56K Sell
125
-19
-13% -$1.14K ﹤0.01% 624
2024
Q1 		$7.72K Buy
+144
New +$7.74K ﹤0.01% 638
2023
Q4 		– Sell
-95
Closed -$4.72K – 608
2023
Q3 		$4.72K Hold
95
– – ﹤0.01% 685
2023
Q2 		$6K Buy
95
+1
+1% +$57 ﹤0.01% 631
2023
Q1 		$5K Hold
94
– – ﹤0.01% 666
2022
Q4 		$7K Buy
94
+23
+32% +$1.57K ﹤0.01% 565
2022
Q3 		$4K Buy
71
+4
+6% +$241 ﹤0.01% 692
2022
Q2 		$4K Hold
67
– – ﹤0.01% 714
2022
Q1 		$5K Hold
67
– – ﹤0.01% 717
2021
Q4 		$5K Sell
67
-4
-6% -$290 ﹤0.01% 742
2021
Q3 		$5K Hold
71
– – ﹤0.01% 732
2021
Q2 		$5K Sell
71
-6
-8% -$427 ﹤0.01% 734
2021
Q1 		$5K Hold
77
– – ﹤0.01% 724
2020
Q4 		$5K Hold
77
– – ﹤0.01% 680
2020
Q3 		$5K Buy
+77
New +$3.97K ﹤0.01% 680

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Front Row Advisors's GMED Position: Q3 2024 in Review

Front Row Advisors sold out of Globus Medical (GMED) in Q3 2024, closing a stake of 125 shares — an estimated $8.56K sold.

Front Row Advisors first reported a position in GMED in Q3 2020 and held it in 15 quarters. The position peaked at $8.56K in Q2 2024. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Front Row Advisors reported no remaining Globus Medical position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 125 Globus Medical shares in Q3 2024, an estimated $8.56K.
  • Front Row Advisors first reported a position in Globus Medical in Q3 2020 and held it in 15 quarters.
  • Front Row Advisors's Globus Medical position peaked at $8.56K in Q2 2024.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.